Genetics /developmental neuropharmacology research unit

$111,111P30FY2000MHNIH

University Of Iowa, Iowa City IA

Investigators

Linked publications & trials

Paper 25228354 Paper 24090512 Paper 23558429 Paper 22945618 Paper 22850347 Paper 22333522 Paper 21876540 Paper 21784414 Paper 21420833 Paper 21300943 Paper 20954434 Paper 20600977 Paper 19760675 Paper 18980790 Paper 18473337 Paper 18056245 Paper 17573374 Paper 16859929 Paper 16818862 Paper 16566898 Paper 16199833 Paper 16169191 Paper 15942998 Paper 15741466 Paper 15705355 Paper 15668720 Paper 15377735 Paper 15184033 Paper 15145469 Paper 15108174 Paper 15099611 Paper 15061245 Paper 14594741 Paper 14593167 Paper 14514490 Paper 13129655 Paper 12814574 Paper 12796222 Paper 12627456 Paper 12505813 Paper 12399138 Paper 12377139 Paper 12216015 Paper 12091197 Paper 12079724 Paper 12074920 Paper 11839951 Paper 11711808 Paper 11677883 Paper 11513374 Paper 11466121 Paper 11396550 Paper 11313038 Paper 11295371 Paper 11241873 Paper 11165313 Paper 11163775 Paper 10924663 Paper 10903407 Paper 10824500 Paper 10784476 Paper 10771410 Paper 10758251 Paper 10708922 Paper 10695895

Abstract

Overall Aims 1. To search for vulnerability loci for schizophrenia. 2. To explore the genetic controls of neurodevelopment as they rate to schizophrenia and other neurodevelopmental brain disorders. 3. To explore the relative roles of genetic and environmental factors in the production of neurodevelopmental disorders. 4. To research for more primary phenotypes (endophenotypes, i.e., personality traits, characteristic brain morphology, patterns of cognitive dysfunction) that may be more closely linked to genotypes than syndromal, criteria-based diagnostic entities.

View original record on NIH RePORTER →